The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Voice Disorders

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Voice Disorders


Psychiatry related information on Voice Disorders


High impact information on Voice Disorders


Chemical compound and disease context of Voice Disorders


Biological context of Voice Disorders


Anatomical context of Voice Disorders


Gene context of Voice Disorders

  • CONCLUSIONS: Reduced dysphonia severity during sustained vowels supports task specificity in ADSD but not MTD and highlights a valuable diagnostic marker whose recognition should contribute to improved diagnostic precision [25].
  • However, some patients presented with dysphonia, dysphagia or cardiomyopathy [26].
  • OBJECTIVES: Two different surgical techniques for midline lateralization thyroplasty (type 2 thyroplasty) for adductor spasmodic dysphonia (SD) have been described, one using a composite graft and the other without [27].
  • Resistance to botulinum toxin injections for spasmodic dysphonia [28].
  • This characteristic facilitates the appropriate selection of patients for biopsy and may spare individuals, who have lesions resulting from hyperfunctional dysphonia and/or gastroesophageal reflux, from unnecessary biopsy [29].

Analytical, diagnostic and therapeutic context of Voice Disorders

  • OBJECTIVE: To evaluate expert listeners' perceptions of voice and fluency in persons with adductor spasmodic dysphonia (ADSD) before and after treatment with botulinum toxin type A (Botox), as a function of initial severity of the disorder (while controlling for patients' age at injection) [30].
  • OBJECTIVE: To study with fMRI the pattern of sensorimotor activation in patients with spasmodic dysphonia (laryngeal dystonia) compared to healthy controls [31].
  • Microinjections of myoneural blocking agents are effective in the treatment of strabismus and have been proposed as a possible technique to treat spastic dysphonia [32].


  1. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Jankovic, J., Ford, J. Ann. Neurol. (1983) [Pubmed]
  2. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Knight, M.A., Gardner, R.J., Bahlo, M., Matsuura, T., Dixon, J.A., Forrest, S.M., Storey, E. Brain (2004) [Pubmed]
  3. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. Toogood, J.H., Jennings, B., Greenway, R.W., Chuang, L. J. Allergy Clin. Immunol. (1980) [Pubmed]
  4. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. Pincus, D.J., Humeston, T.R., Martin, R.J. J. Allergy Clin. Immunol. (1997) [Pubmed]
  5. Laryngeal botulinum toxin injections for disabling stuttering in adults. Brin, M.F., Stewart, C., Blitzer, A., Diamond, B. Neurology (1994) [Pubmed]
  6. Laryngeal electromyography in movement disorders: preliminary data. Kimaid, P.A., Quagliato, E.M., Crespo, A.N., Wolf, A., Viana, M.A., Resende, L.A. Arquivos de neuro-psiquiatria. (2004) [Pubmed]
  7. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. Bennedbaek, F.N., Hegedüs, L. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  8. Salmeterol/fluticasone propionate combination. Spencer, C.M., Jarvis, B. Drugs (1999) [Pubmed]
  9. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Williams, A.J., Baghat, M.S., Stableforth, D.E., Cayton, R.M., Shenoi, P.M., Skinner, C. Thorax (1983) [Pubmed]
  10. Spasmodic dysphonia induced by valproic acid. Oh, J., Park, K.D., Cho, H.J., Choi, K.G., Jung, S.M. Epilepsia (2004) [Pubmed]
  11. Alkalinization of intra-cuff lidocaine and use of gel lubrication protect against tracheal tube-induced emergence phenomena. Estebe, J.P., Delahaye, S., Le Corre, P., Dollo, G., Le Naoures, A., Chevanne, F., Ecoffey, C. British journal of anaesthesia. (2004) [Pubmed]
  12. Nebulized lidocaine in the treatment of refractory cough. Trochtenberg, S. Chest (1994) [Pubmed]
  13. Dysphonia secondary to perindopril treatment. Vázquez, F.J. Am. J. Hypertens. (2003) [Pubmed]
  14. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Mackey, J.R., Desai, S., Larratt, L., Cwik, V., Nabholtz, J.M. Bone Marrow Transplant. (1997) [Pubmed]
  15. Dysphonia, an uncommon symptom of systemic neurotoxic envenomation by Vipera aspis bite. Report of two cases. Beer, E., Putorti, F. Toxicon (1998) [Pubmed]
  16. Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge. Isshiki, N., Yamamoto, I., Fukagai, S. Acta Otolaryngol. (2004) [Pubmed]
  17. Speech intelligibility in severe adductor spasmodic dysphonia. Bender, B.K., Cannito, M.P., Murry, T., Woodson, G.E. J. Speech Lang. Hear. Res. (2004) [Pubmed]
  18. Does botulinum toxin alter laryngeal secretions and mucociliary transport? Fisher, K.V., Giddens, C.L., Gray, S.D. Journal of voice : official journal of the Voice Foundation. (1998) [Pubmed]
  19. Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience. Tisch, S.H., Brake, H.M., Law, M., Cole, I.E., Darveniza, P. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. (2003) [Pubmed]
  20. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. Sapienza, C.M., Walton, S., Murry, T. Journal of voice : official journal of the Voice Foundation. (2000) [Pubmed]
  21. Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy. Muta, D., Goto, S., Nishikawa, S., Hamasaki, T., Ushio, Y., Inoue, N., Mita, S. Mov. Disord. (2001) [Pubmed]
  22. Dysphonia associated with epidural steroid injection: a case report. Slipman, C.W., Chow, D.W., Lenrow, D.A., Blaugrund, J.E., Chou, L.H. Archives of physical medicine and rehabilitation. (2002) [Pubmed]
  23. Amyloid deposits in the trachea and esophagus ultrastructural confirmation. Busuttil, A., More, I.A., Jones, D.G. Laryngoscope (1976) [Pubmed]
  24. Contemporary management of spasmodic dysphonia. Sulica, L. Current opinion in otolaryngology & head and neck surgery. (2004) [Pubmed]
  25. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia. Roy, N., Gouse, M., Mauszycki, S.C., Merrill, R.M., Smith, M.E. Laryngoscope (2005) [Pubmed]
  26. Familial desmin myopathies and cytoplasmic body myopathies. Baeta, A.M., Figarella-Branger, D., Bille-Turc, F., Lepidi, H., Pellissier, J.F. Acta Neuropathol. (1996) [Pubmed]
  27. Thyroplasty for adductor spasmodic dysphonia: further experiences. Isshiki, N., Haji, T., Yamamoto, Y., Mahieu, H.F. Laryngoscope (2001) [Pubmed]
  28. Resistance to botulinum toxin injections for spasmodic dysphonia. Smith, M.E., Ford, C.N. Arch. Otolaryngol. Head Neck Surg. (2000) [Pubmed]
  29. Premalignant epithelium and microinvasive cancer of the vocal fold: the evolution of phonomicrosurgical management. Zeitels, S.M. Laryngoscope (1995) [Pubmed]
  30. Perceptual analyses of spasmodic dysphonia before and after treatment. Cannito, M.P., Woodson, G.E., Murry, T., Bender, B. Arch. Otolaryngol. Head Neck Surg. (2004) [Pubmed]
  31. "Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Haslinger, B., Erhard, P., Dresel, C., Castrop, F., Roettinger, M., Ceballos-Baumann, A.O. Neurology (2005) [Pubmed]
  32. Three-dimensional distribution of neuromuscular junctions in human cricothyroid. De Vito, M.A., Malmgren, L.T., Gacek, R.R. Archives of otolaryngology (Chicago, Ill. : 1960) (1985) [Pubmed]
WikiGenes - Universities